Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal. CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a clinical-stage biopharmaceutical company focused on developing its...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal while Goodwin Procter represented Amylyx Pharmaceuticals. Amylyx Pharmaceuticals, Inc. (“Amylyx”), a clinical-stage pharmaceutical company...
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom advised Stryker on the deal, while Fenwick & West represented Vocera Communications. Debevoise & Plimpton advised Evercore LLC as financial...
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom advised DuPont on the deal while Covington & Burling represented Rogers Corporation. Fried Frank acted as counsel to Evercore as...
You must be a Standard 1 Year member to access this content.
Shearman & Sterling advised Evercore ISI as the sole book-running manager on the initial public offering. Learn CW Investment, a SPAC, executed its 23 million units...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Thorne HealthTech, while Latham & Watkins represented the underwriters in the offering. Thorne HealthTech, a leader in developing innovative solutions...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal. Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company advancing new treatments for patients suffering...
You must be a Standard 1 Year member to access this content.
White & Case advised AMCI, while Cravath, Swaine & Moore advised the underwriters in the transaction. AMCI Acquisition Corp. II executed the $150 million initial public offering...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. Eliem Therapeutics, Inc., a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to...
You must be a Standard 1 Year member to access this content.
Simpson Thacher advised Gates Industrial Corporation, while Davis Polk advised the representatives of the underwriters in the offering. Gates Industrial Corporation announced a secondary offering of...
You must be a Standard 1 Year member to access this content.
Ashurst advised Evercore Partners International LLP on the deal. Macfarlanes and Kirkland & Ellis advised NortonLifeLock Inc. White & Case LLP advised Avast plc. On completion...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Icosavax, while Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal. Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its...
You must be a Standard 1 Year member to access this content.
